|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Sugar binding protein, hormone
|
 |
|
Title:
|
 |
Islet amyloid polypeptide (iapp or amylin) fused to maltose protein
|
|
Structure:
|
 |
Maltose-binding periplasmic protein, islet amyloi polypeptide fusion protein. Chain: a, b, c, d. Synonym: mmbp, maltodextrin-binding protein, amylin, diabet associated peptide, dap, insulinoma amyloid peptide. Engineered: yes
|
|
Source:
|
 |
Escherichia coli, homo sapiens. Organism_taxid: 83333,9606. Gene: male, b4034, jw3994, iapp. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
1.86Å
|
R-factor:
|
0.178
|
R-free:
|
0.205
|
|
|
Authors:
|
 |
J.J.W.Wiltzius,M.R.Sawaya,D.Eisenberg
|
|
Key ref:
|
 |
J.J.Wiltzius
et al.
(2009).
Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process.
Protein Sci,
18,
1521-1530.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
10-Feb-09
|
Release date:
|
23-Jun-09
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
3 terms
|
 |
|
Biological process
|
transport
|
4 terms
|
 |
|
Biochemical function
|
transporter activity
|
5 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Protein Sci
18:1521-1530
(2009)
|
|
PubMed id:
|
|
|
|
|
| |
|
Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process.
|
|
J.J.Wiltzius,
S.A.Sievers,
M.R.Sawaya,
D.Eisenberg.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Islet Amyloid Polypeptide (IAPP or amylin) is a peptide hormone produced and
stored in the beta-islet cells of the pancreas along with insulin. IAPP readily
forms amyloid fibrils in vitro, and the deposition of fibrillar IAPP has been
correlated with the pathology of type II diabetes. The mechanism of the
conversion that IAPP undergoes from soluble to fibrillar forms has been unclear.
By chaperoning IAPP through fusion to maltose binding protein, we find that IAPP
can adopt a alpha-helical structure at residues 8-18 and 22-27 and that
molecules of IAPP dimerize. Mutational analysis suggests that this dimerization
is on the pathway to fibrillation. The structure suggests how IAPP may
heterodimerize with insulin, which we confirmed by protein crosslinking. Taken
together, these experiments suggest the helical dimerization of IAPP accelerates
fibril formation and that insulin impedes fibrillation by blocking the IAPP
dimerization interface.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
P.Cao,
F.Meng,
A.Abedini,
and
D.P.Raleigh
(2010).
The ability of rodent islet amyloid polypeptide to inhibit amyloid formation by human islet amyloid polypeptide has important implications for the mechanism of amyloid formation and the design of inhibitors.
|
| |
Biochemistry, 49,
872-881.
|
 |
|
|
|
|
 |
P.Marek,
S.Mukherjee,
M.T.Zanni,
and
D.P.Raleigh
(2010).
Residue-specific, real-time characterization of lag-phase species and fibril growth during amyloid formation: a combined fluorescence and IR study of p-cyanophenylalanine analogs of islet amyloid polypeptide.
|
| |
J Mol Biol, 400,
878-888.
|
 |
|
|
|
|
 |
S.Scalisi,
M.F.Sciacca,
G.Zhavnerko,
D.M.Grasso,
G.Marletta,
and
C.La Rosa
(2010).
Self-assembling pathway of HiApp fibrils within lipid bilayers.
|
| |
Chembiochem, 11,
1856-1859.
|
 |
|
|
|
|
 |
U.Hinz,
R.Apweiler,
M.J.Martin,
C.O'Donovan,
M.Magrane,
Y.Alam-Faruque,
R.Antunes,
D.Barrell,
B.Bely,
M.Bingley,
D.Binns,
L.Bower,
P.Browne,
W.M.Chan,
E.Dimmer,
R.Eberhardt,
A.Fedotov,
R.Foulger,
J.Garavelli,
R.Huntley,
J.Jacobsen,
M.Kleen,
K.Laiho,
R.Leinonen,
D.Legge,
Q.Lin,
W.Liu,
J.Luo,
S.Orchard,
S.Patient,
D.Poggioli,
M.Pruess,
M.Corbett,
G.di Martino,
M.Donnelly,
P.van Rensburg,
A.Bairoch,
L.Bougueleret,
I.Xenarios,
S.Altairac,
A.Auchincloss,
G.Argoud-Puy,
K.Axelsen,
D.Baratin,
M.C.Blatter,
B.Boeckmann,
J.Bolleman,
L.Bollondi,
E.Boutet,
S.B.Quintaje,
L.Breuza,
A.Bridge,
E.de Castro,
L.Ciapina,
D.Coral,
E.Coudert,
I.Cusin,
F.David,
G.Delbard,
M.Doche,
D.Dornevil,
P.D.Roggli,
S.Duvaud,
A.Estreicher,
L.Famiglietti,
M.Feuermann,
S.Gehant,
N.Farriol-Mathis,
S.Ferro,
E.Gasteiger,
A.Gateau,
V.Gerritsen,
A.Gos,
N.Gruaz-Gumowski,
U.Hinz,
C.Hulo,
N.Hulo,
J.James,
S.Jimenez,
F.Jungo,
T.Kappler,
G.Keller,
C.Lachaize,
L.Lane-Guermonprez,
P.Langendijk-Genevaux,
V.Lara,
P.Lemercier,
D.Lieberherr,
T.d.e. .O.Lima,
V.Mangold,
X.Martin,
P.Masson,
M.Moinat,
A.Morgat,
A.Mottaz,
S.Paesano,
I.Pedruzzi,
S.Pilbout,
V.Pillet,
and
S.Poux
(2010).
From protein sequences to 3D-structures and beyond: the example of the UniProt knowledgebase.
|
| |
Cell Mol Life Sci, 67,
1049-1064.
|
 |
|
|
|
|
 |
Z.S.Derewenda
(2010).
Application of protein engineering to enhance crystallizability and improve crystal properties.
|
| |
Acta Crystallogr D Biol Crystallogr, 66,
604-615.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
|